Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FLOLAN
- Nebulized Epoprostenol (FLOLAN) and Phenylephrine on One Lung Ventilation (OLV)
- Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects
- Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)
- Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage
- Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension
- Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg
- Study on the Effect of Prostacyclin Compared to Placebo in Traumatic Brain Injury
- Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401
- Epoprostenol for Injection in Pulmonary Arterial Hypertension
- Epoprostenol in Pulmonary Embolism
- Rapid Switch From Flolan to Remodulin in the Outpatient Clinic
- Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
- Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
- Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin
- A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension
- Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
Clinical trials list
click for details